GemmaCert

GemmaCert

Be Certain.

Founded 2015 Israel

Israel 10 employees Venture round Total: $18.25M Biotechnology, Health Care +2

GemmaCert is a biotechnology startup based in Israel, founded in 2015, that has introduced the world's first truly non-destructive and non-invasive analytical device for verifying the potency of Cannabis and Hemp flowers. The company's slogan, "Be Certain," reflects its commitment to providing accurate and reliable results to cannabis industry stakeholders including growers, processors, distributors, and dispensaries. The technology developed by GemmaCert eliminates the need for solvents or grinding as it requires no sample preparation, keeping the flowers intact and undamaged after analysis. Leveraging advanced optics and imaging analysis, their proprietary technology addresses the challenges posed by the heterogeneous nature of cannabis flowers. Additionally, an integrated cloud database, sorting and labeling functionality, traceable packaging, and mobile apps complement their offering. The last investment, a $1.00M Venture Round investment on 12 January 2021, was led by Neo Ventures. GemmaCert's innovation brings several advantages to its users, including higher levels of quality assurance, operational efficiency, and increased customer loyalty, contributing to enhanced positive commercial performance. With its commitment to certainty and the slogan #becertain #stopguessing, GemmaCert is poised to make a significant impact in the cannabis industry.

Funding Stage	Amount	Investors	Lead Investors	Date
Venture Round	$1.00M	1	Neo Ventures	12 Jan 2021
Series B	ILS12.00M	1	Hebrew University of Jerusalem	18 Aug 2019
Convertible Note	$2.00M	-		01 Jun 2018
Series A	$2.25M	3	Neo Ventures, Stony Hill Corp +1	13 Feb 2018
Seed Round	$1.00M	3	Agrinnovation, Mayham Holding AG +1	01 Feb 2017

Funding Stage

Amount

Investors

Lead Investors

Date

Venture Round

$1.00M

Neo Ventures

12 Jan 2021

Series B

ILS12.00M

Hebrew University of Jerusalem

18 Aug 2019

Convertible Note

$2.00M

01 Jun 2018

Series A

$2.25M

Neo Ventures, Stony Hill Corp +1

13 Feb 2018

Seed Round

$1.00M

Agrinnovation, Mayham Holding AG +1

01 Feb 2017

FAQ About GemmaCert

Be Certain.

GemmaCert was founded in 2015.

GemmaCert is headquartered in Israel.

GemmaCert operates in Biotechnology, Health Care, Life Sciences and AgriTech. Its work centres on Cannabis Technology, Analytical Devices, Medical Cannabis and Hemp Industry.

GemmaCert has approximately 10 employees.

GemmaCert has completed 5 funding rounds, raising a total of $18.25M. The latest funding stage is Venture round.

Top alternatives and competitors to GemmaCert include Digipath, Inc. , TTS Pharma Ltd, Paratus Diagnostics, eNeura, Endofotonics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

GemmaCert and Digipath, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

General Information

Discover More

About GemmaCert

Funding Rounds & Investors (5)

GemmaCert Alternatives & Competitors

FAQ About GemmaCert